Pest and Environmental Adaptation Research Group, Bio21 Institute and the School of BioSciences, The University of Melbourne, Parkville, Victoria, Australia.
Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, Queensland, Australia.
PLoS Pathog. 2022 Feb 23;18(2):e1010256. doi: 10.1371/journal.ppat.1010256. eCollection 2022 Feb.
Mosquitoes carrying Wolbachia endosymbionts are being released in many countries for arbovirus control. The wMel strain of Wolbachia blocks Aedes-borne virus transmission and can spread throughout mosquito populations by inducing cytoplasmic incompatibility. Aedes aegypti mosquitoes carrying wMel were first released into the field in Cairns, Australia, over a decade ago, and with wider releases have resulted in the near elimination of local dengue transmission. The long-term stability of Wolbachia effects is critical for ongoing disease suppression, requiring tracking of phenotypic and genomic changes in Wolbachia infections following releases. We used a combination of field surveys, phenotypic assessments, and Wolbachia genome sequencing to show that wMel has remained stable in its effects for up to a decade in Australian Ae. aegypti populations. Phenotypic comparisons of wMel-infected and uninfected mosquitoes from near-field and long-term laboratory populations suggest limited changes in the effects of wMel on mosquito fitness. Treating mosquitoes with antibiotics used to cure the wMel infection had limited effects on fitness in the next generation, supporting the use of tetracycline for generating uninfected mosquitoes without off-target effects. wMel has a temporally stable within-host density and continues to induce complete cytoplasmic incompatibility. A comparison of wMel genomes from pre-release (2010) and nine years post-release (2020) populations show few genomic differences and little divergence between release locations, consistent with the lack of phenotypic changes. These results indicate that releases of Wolbachia-infected mosquitoes for population replacement are likely to be effective for many years, but ongoing monitoring remains important to track potential evolutionary changes.
携带沃尔巴克氏体共生菌的蚊子正在许多国家被释放用于控制虫媒病毒。沃尔巴克氏体的 wMel 株能阻断登革热病毒的传播,并通过诱导细胞质不相容性在蚊群中传播。携带 wMel 的埃及伊蚊首先在澳大利亚凯恩斯野外释放,经过更广泛的释放,当地登革热传播已接近消除。沃尔巴克氏体效应的长期稳定性对于持续的疾病抑制至关重要,这需要在释放后跟踪沃尔巴克氏体感染的表型和基因组变化。我们采用现场调查、表型评估和沃尔巴克氏体基因组测序相结合的方法,表明 wMel 在澳大利亚埃及伊蚊种群中长达十年的时间内其效应保持稳定。来自近场和长期实验室种群的感染和未感染的 wMel 蚊子的表型比较表明,wMel 对蚊子适应度的影响变化有限。用用于治疗 wMel 感染的抗生素处理蚊子对下一代的适应度影响有限,支持使用四环素生成未感染的蚊子而不会产生脱靶效应。wMel 在宿主内具有稳定的时间密度,并继续诱导完全细胞质不相容性。对释放前(2010 年)和释放后九年(2020 年)种群的 wMel 基因组进行比较,显示基因组差异很少,释放地点之间差异很小,这与表型变化很少一致。这些结果表明,用于种群替换的携带沃尔巴克氏体感染的蚊子的释放很可能在未来多年内有效,但持续监测仍然很重要,以跟踪潜在的进化变化。